Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
Presynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference...
Main Authors: | Daniele Marcotulli, Giorgia Fattorini, Luca Bragina, Jessica Perugini, Fiorenzo Conti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/full |
Similar Items
-
HETEROGENEITY OF PRESYNAPTIC PROTEINS: DO NOT FORGET ISOFORMS
by: Luca eBragina, et al.
Published: (2013-02-01) -
Two Behavioral Tests Allow a Better Correlation Between Cognitive Function and Expression of Synaptic Proteins
by: Marta Balietti, et al.
Published: (2018-04-01) -
Analysis of synaptotagmin, SV2, and Rab3 expression in cortical glutamatergic and GABAergic axon terminals
by: Luca eBragina, et al.
Published: (2012-01-01) -
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
by: Maria Daniela Cirnaru, et al.
Published: (2014-05-01) -
A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus
by: Daniel G. Calame, et al.
Published: (2021-01-01)